Agilon Health (NYSE:AGL) Shares Gap Up – What’s Next?

Agilon Health, Inc. (NYSE:AGL) gapped up prior to trading on Tuesday . The stock had previously closed at $92.38, but opened at $96.25. Agilon Health shares last traded at $94.5610, with a volume of 15,126 shares changing hands.

Wall Street Analyst Weigh In

A number of research firms have weighed in on AGL. Royal Bank Of Canada set a $125.00 target price on shares of Agilon Health in a report on Tuesday. Wells Fargo & Company reaffirmed an “overweight” rating and set a $146.00 price target (up from $141.00) on shares of Agilon Health in a research note on Tuesday, August 11th. Truist Financial set a $112.00 price target on shares of Agilon Health and gave the stock a “hold” rating in a report on Thursday, August 6th. Sanford C. Bernstein raised shares of Agilon Health from a “market perform” rating to an “outperform” rating and boosted their price objective for the stock from $86.00 to $125.00 in a research note on Tuesday. Finally, Robert W. Baird set a $116.00 price objective on shares of Agilon Health in a research note on Thursday, August 6th. Six analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $102.25.

Agilon Health Price Performance

The firm has a market capitalization of $1.60 billion, a P/E ratio of -6.55 and a beta of 3.02. The company has a fifty day moving average of $99.47 and a 200 day moving average of $70.07. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.08 and a quick ratio of 1.08.

Agilon Health (NYSE:AGL) last released its quarterly earnings results on Wednesday, August 5th. The company reported $1.04 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.90. The firm had revenue of $1.49 billion during the quarter, compared to analyst estimates of $1.45 billion. Agilon Health had a negative net margin of 3.92% and a negative return on equity of 119.38%. Sell-side analysts predict that Agilon Health, Inc. will post -2.9 earnings per share for the current year.

Hedge Funds Weigh In On Agilon Health

Hedge funds have recently bought and sold shares of the company. North Peak Capital Management LLC lifted its holdings in Agilon Health by 10.8% in the fourth quarter. North Peak Capital Management LLC now owns 38,139,937 shares of the company’s stock valued at $26,267,000 after buying an additional 3,715,460 shares during the period. Rubicon Founders LLC bought a new stake in Agilon Health during the second quarter valued at $11,290,448. Bank of New York Mellon Corp grew its holdings in Agilon Health by 9.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 35,336 shares of the company’s stock worth $3,787,000 after acquiring an additional 3,074 shares during the period. UBS Group AG grew its holdings in Agilon Health by 250.7% during the 4th quarter. UBS Group AG now owns 3,395,366 shares of the company’s stock worth $2,339,000 after acquiring an additional 2,427,136 shares during the period. Finally, California State Teachers Retirement System bought a new position in shares of Agilon Health in the 2nd quarter worth about $1,976,000.

Agilon Health Company Profile

Agilon Health, Inc is a healthcare company that partners with independent primary care physicians to support the transition from fee-for-service medicine to value-based care. The company focuses primarily on patients enrolled in Medicare Advantage plans and works with physician groups to coordinate care, improve outcomes and manage healthcare costs.

Agilon provides physicians with technology, analytics, operational support and clinical resources designed to help them manage the health of defined patient populations.